British Journal of Cancer · 2015 · 56 citations · 14 references
MedicineOncologyToxicologyCarcinogenesisMolecular OncologyNeoplasiaKidney CancerMalignant NeoplasmsNephrotoxicity MechanismsRenal Cell CarcinomaRenal NeoplasmsRenal ToxicityDna Adduct BiomarkersDna Adduct MeasurementKidney Cancer EpidemiologyMass Spectrometric DetectionMass Spectrometric IdentificationMass Spectrometric QuantificationRenal Cell Carcinoma Biomarkers
BACKGROUND: Aristolochic acid (AA) is a nephrotoxicant associated with AA nephropathy (AAN) and upper urothelial tract cancer (UUTC). Whole-genome sequences of 14 Romanian cases of renal cell carcinoma (RCC) recently exhibited mutational signatures consistent with AA exposure, although RCC had not been previously linked with AAN and AA exposure was previously reported only in localised rural areas. METHODS: We performed mass spectrometric measurements of the aristolactam (AL) DNA adduct 7-(deoxyadenosin-N(6)-yl) aristolactam I (dA-AL-I) in nontumour renal tissues of the 14 Romanian RCC cases and 15 cases from 3 other countries. RESULTS: We detected dA-AL-I in the 14 Romanian cases at levels ranging from 0.7 to 27 adducts per 10(8) DNA bases, in line with levels reported in Asian and Balkan populations exposed through herbal remedies or food contamination. The 15 cases from other countries were negative. INTERPRETATION: Although the source of exposure is uncertain and likely different in AAN regions than elsewhere, our results demonstrate that AA exposure in Romania exists outside localised AAN regions and provide further evidence implicating AA in RCC.
14
Aristolochic acid-associated urothelial cancer in Taiwan
Chung‐Hsin Chen, Kathleen G. Dickman, Masaaki Moriya et al. · Proceedings of the National Academy of Sciences · 2012 · 414 citations · Full text
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scélo, Yasser Riazalhosseini, Liliana Greger et al. · Nature Communications · 2014 · 200 citations · Full text